Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CORV

Correvio Pharma (CORV) Stock Price, News & Analysis

About Correvio Pharma Stock (NASDAQ:CORV)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.42
50-Day Range
$0.39
$0.42
52-Week Range
$0.21
$2.79
Volume
N/A
Average Volume
5.35 million shs
Market Capitalization
$27.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CORV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Correvio Pharma and its competitors with MarketBeat's FREE daily newsletter.

CORV Stock News Headlines

Corvus Pharmaceuticals announces preclinical dataon soquelitinib
Corvus Pharmaceuticals options imply 17.7% move in share price post-earnings
This Crypto Is Set to Explode in January
This Could Be the Most Important Crypto Law in History While the world celebrates Bitcoin becoming 2025’s top-performing asset, smart hedge funds are accumulating elsewhere. During the upcoming Crypto Hedge Fund Summit, you'll discover exactly which coins they’ve loaded up on before this historic vote.
An Overview of Corvus Pharma's Earnings
Atea Pharmaceuticals Advances in HCV Treatment Development
See More Headlines

CORV Stock Analysis - Frequently Asked Questions

Correvio Pharma Corp (NASDAQ:CORV) released its earnings results on Monday, March, 30th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.06. The business had revenue of $11.33 million for the quarter, compared to the consensus estimate of $11.52 million. Correvio Pharma had a negative trailing twelve-month return on equity of 2,128.82% and a negative net margin of 107.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Correvio Pharma investors own include Inovio Pharmaceuticals (INO), NightHawk Biosciences (NHWK), SCYNEXIS (SCYX), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), Oncobiologics (OTLK) and Vaxart (VXRT).

Company Calendar

Last Earnings
3/30/2020
Today
8/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CORV
CIK
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.18 million
Net Margins
-107.81%
Pretax Margin
N/A
Return on Equity
-2,128.82%
Return on Assets
-58.56%

Debt

Debt-to-Equity Ratio
22.54
Current Ratio
1.07
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$32.63 million
Price / Sales
0.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-21.00

Miscellaneous

Outstanding Shares
66,191,000
Free Float
N/A
Market Cap
$27.80 million
Optionable
Optionable
Beta
0.08
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CORV) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners